Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Human endogenous retroviruses and cancer

María Gonzalez-Cao, Paola Iduma, Niki Karachaliou, Mariacarmela Santarpia, Julià Blanco and Rafael Rosell
Cancer Biology & Medicine December 2016, 13 (4) 483-488; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0080
María Gonzalez-Cao
1Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona 08028, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Paola Iduma
2AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona 08028, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niki Karachaliou
1Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona 08028, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariacarmela Santarpia
3Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, 98122, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julià Blanco
2AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona 08028, Spain
4UVIC-UCC, Catalunya 08500, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael Rosell
1Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona 08028, Spain
5Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias I Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, 08916, Spain
6Fundación Molecular Oncology Research, Barcelona 08028, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    1

    Mechanisms of oncogenesis. LTRs recruit transcription factors from the infected cell for retroviral gene transcription. These LTRs can also enhance transcription of the host cell genes, leading to uncontrolled tumor cell proliferation. Some HERVs encode potentially oncogenic proteins like Np9 and Rec that interact with transcription factors and activate immunosuppressor pathways, promoting oncogenesis. HERVs can also induce chromosomal translocations in somatic cells that could lead to tumor proliferation. HERVs also can promote an immunosuppressive response that may lead to cancer formation and spreading, because the Env protein has an immunosuppressive domain (ISD).

  • 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    2

    Retranscription of HERVs would activate the innate response of sensors (pattern-recognition receptors or PRRs) of single RNA strand (RIG1 and MDA5) in cytosol of the cancer cells. This activates the signaling pathways leading to activation of TRAF family member-associated NF-κB activator (TANK)-binding kinase 1 (TBK1) that causes induction of the IFN-regulatory factor-3 and 7 (IRF-3 and IRF-7), NF-KB-dependent gene expression and subsequent production of IFN beta. This results in transcriptional activation of interferon stimulated genes with the production of cytokines, and increased expression of MHC type I on cancer cells.

PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 13 (4)
Cancer Biology & Medicine
Vol. 13, Issue 4
1 Dec 2016
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Human endogenous retroviruses and cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Human endogenous retroviruses and cancer
María Gonzalez-Cao, Paola Iduma, Niki Karachaliou, Mariacarmela Santarpia, Julià Blanco, Rafael Rosell
Cancer Biology & Medicine Dec 2016, 13 (4) 483-488; DOI: 10.20892/j.issn.2095-3941.2016.0080

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Human endogenous retroviruses and cancer
María Gonzalez-Cao, Paola Iduma, Niki Karachaliou, Mariacarmela Santarpia, Julià Blanco, Rafael Rosell
Cancer Biology & Medicine Dec 2016, 13 (4) 483-488; DOI: 10.20892/j.issn.2095-3941.2016.0080
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • HERVs: structure and function
    • HERV and cancer
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Mechanisms underlying prostate cancer sensitivity to reactive oxygen species: overcoming radiotherapy resistance and recent clinical advances
  • Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches
  • Multi-omics in colorectal cancer liver metastasis: applications and research advances
Show more Review

Similar Articles

Keywords

  • HERVs
  • cancer
  • interferon
  • immunotherapy

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire